Spok Holdings, Inc.
$11.48
▲
0.36%
2026-04-21 09:34:01
www.spok.com
NMS: SPOK
Explore Spok Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$237.98 M
Current Price
$11.48
52W High / Low
$19.31 / $10.81
Stock P/E
14.99
Book Value
$7.1
Dividend Yield
10.89%
ROCE
12.85%
ROE
10.55%
Face Value
—
EPS
$0.75
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
421
Beta
0.47
Debt / Equity
4.74
Current Ratio
1.18
Quick Ratio
1.18
Forward P/E
13.23
Price / Sales
1.65
Enterprise Value
$211.97 M
EV / EBITDA
8.98
EV / Revenue
1.52
Rating
None
Target Price
$14
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Certara, Inc. | $6.19 | — | $989.85 M | — | 1.5% | -0.15% | $15.38 / $5.19 | $6.68 |
| 2. | 10x Genomics, Inc. | $24.59 | — | $3.14 B | — | -12.49% | -5.78% | $26.45 / $7.25 | $6.24 |
| 3. | Teladoc Health, Inc. | $6.1 | — | $1.09 B | — | -6.66% | -13.93% | $9.77 / $4.4 | $7.77 |
| 4. | Doximity, Inc. | $24.39 | 19.07 | $4.56 B | — | 20.77% | 23.82% | $76.51 / $20.55 | $5.29 |
| 5. | Forian Inc. | $2.16 | — | $67.1 M | — | -8.29% | -9.61% | $2.71 / $1.64 | $0.96 |
| 6. | American Well Corporation | $6.61 | — | $101.3 M | — | -42.01% | -33.67% | $9.15 / $3.71 | $14.34 |
| 7. | VSee Health, Inc. | $0.24 | — | $11.87 M | — | -476.79% | -5.42% | $2.52 / $0.19 | $-0.33 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 33.86 M | 33.87 M | 35.69 M | 36.29 M | 33.89 M | — |
| Operating Profit | 4.15 M | 4.53 M | 5.41 M | 6.08 M | 4.6 M | — |
| Net Profit | 2.93 M | 3.2 M | 4.55 M | 5.2 M | 3.64 M | — |
| EPS in Rs | 0.14 | 0.15 | 0.22 | 0.25 | 0.18 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 139.71 M | 137.65 M | 139.03 M | 134.53 M |
| Operating Profit | 20.17 M | 20.07 M | 21.8 M | 7.57 M |
| Net Profit | 15.88 M | 14.96 M | 15.67 M | 21.86 M |
| EPS in Rs | 0.77 | 0.72 | 0.76 | 1.05 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 206.11 M | 217.1 M | 227.68 M | 244.48 M |
| Total Liabilities | 59.73 M | 62.36 M | 63.91 M | 73.38 M |
| Equity | 146.38 M | 154.75 M | 163.77 M | 171.1 M |
| Current Assets | 57.88 M | 61.3 M | 63.89 M | 70.05 M |
| Current Liabilities | 49.11 M | 48.77 M | 48.01 M | 54.43 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 28.95 M | 28.92 M | 26.18 M | 6.46 M |
| Investing CF | -3.05 M | -3.21 M | -3.42 M | 11.26 M |
| Financing CF | -29.79 M | -28.54 M | -26.68 M | -26.22 M |
| Free CF | 25.2 M | 25.71 M | 22.77 M | 2.68 M |
| Capex | -3.75 M | -3.21 M | -3.42 M | -3.78 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -0.99% | 3.34% | — | — |
| Earnings Growth % | -4.47% | -28.32% | — | — |
| Profit Margin % | 10.87% | 11.27% | 16.25% | — |
| Operating Margin % | 14.58% | 15.68% | 5.62% | — |
| Gross Margin % | 79.15% | 80.51% | 78.99% | — |
| EBITDA Margin % | 17.59% | 18.92% | 8.28% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-16 | $0.313 |
| 2025-11-18 | $0.313 |
| 2025-08-19 | $0.313 |
| 2025-05-23 | $0.313 |
| 2025-03-14 | $0.313 |
Stock Splits
No stock split history available.